Waters Corporation (WAT) — Fair Value Analysis

Base-case fair value (P50): $330.69 · Current price: $334.70 · Verdict: Fairly Valued

The Verdict on WAT

Waters Corporation (WAT), a key player in the Healthcare sector, currently trades at $334.70, positioning it very close to its Monte Carlo-derived median fair value (P50) of $330.69. Our simulations indicate the stock is Fairly Valued, with an implied -1.2% against the current market price. This tight alignment between the market and our probabilistic models suggests that WAT's present valuation largely reflects its fundamental outlook, leaving little immediate edge based solely on this median fair value assessment.

How WAT stacks up against Healthcare

While Waters Corporation's $334.70 aligns closely with our $330.69 estimate, the company’s operational and financial health is characterized by a weak quality tier when benchmarked against its Healthcare sector peers. This weak quality tier implies that despite the stock appearing fairly valued by our simulations, underlying fundamentals may present greater relative risk or less robust performance compared to other opportunities within the sector. Investors evaluating the minimal -1.2% should weigh this quality assessment carefully.

What this means for investors

For investors considering Waters Corporation, the Fairly Valued verdict, combined with a weak quality tier, signals a need for caution beyond simple price-to-fair-value comparisons. The current $334.70 offers an -1.2% relative to the $330.69 that is largely negligible. FairCurve’s comprehensive Monte Carlo analysis suggests the market has largely priced in the known variables. To gain deeper insight into potential downside scenarios and more optimistic bull cases, sign up for FairCurve to see the full bear/bull distribution and track WAT's fair value as new fundamentals are released.